Norbert Kraut

发表

BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo

Péter Lénárt, Wolfgang J. Rettig, Jan-Michael Peters, 2007, Current Biology.

Quantitative Phospho-proteomics to Investigate the Polo-like Kinase 1-Dependent Phospho-proteome*

Otto Hudecz, Karl Mechtler, Jonathan Rameseder, 2011, Molecular & Cellular Proteomics.

Systematic Phosphorylation Analysis of Human Mitotic Protein Complexes

Otto Hudecz, Karl Mechtler, Jean-Karim Hériché, 2011, Science Signaling.

Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation

Rüdiger Klein, Markus Reschke, Wolfgang Sommergruber, 2006, Nature Medicine.

NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

Andreas Sommer, H. Pehamberger, H. Beug, 2004 .

Expression profiling of epithelial plasticity in tumor progression

Thomas Waerner, H. Beug, S. Lüdemann, 2003, Oncogene.

Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle.

Jan-Michael Peters, J. Peters, N. Kraut, 2007, Developmental cell.